If the AI capex narrative is losing momentum then Jefferies strategist Chris Wood can recommen some sectors , like pharma, and some markets like India, Brazil and China, as ways to play that slowdown.
Midterm elections provided the hyperscalers with the excuse they needed to cut back on spending, says Jefferies strategist
In short
Recent political cycles gave large-scale technology firms the justification needed to decrease overall spending. If capital expenditures in artificial intelligence decelerate, investors should identify new opportunities across non-tech industries and overseas markets. Jefferies strategist Chris Wood explicitly highlights pharmaceuticals as a key sector positioned to navigate this pullback. Furthermore, geographic diversification presents viable strategies to offset the domestic tech investment slowdown.
Key points
- Hyperscalers are actively pulling back capital expenditure following the recent midterm e…: Hyperscalers are actively pulling back capital expenditure following the recent midterm elections cycle.
- Investors concerned about slowing artificial intelligence spending should explore non-tec…: Investors concerned about slowing artificial intelligence spending should explore non-tech sectors like pharmaceuticals.
- Expanding asset exposure into markets like China, Brazil, and India offers protection aga…: Expanding asset exposure into markets like China, Brazil, and India offers protection against decelerating tech outlays.